Paper33197893
CD138- multiple myeloma cells express high level of CHK1 which correlated to overall survival in MM patient.
Wu D and 7 others. Aging (Albany NY), 2020. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. CD138- multiple myeloma cells express high level of CHK1 which correlated to overall survival in MM patient. Papers, record 33197893. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33197893
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CD138- multiple myeloma cells express high level of CHK1 which correlated to overall survival in MM patient.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Checkpoint Kinase 1 | Major topic |
| Multiple Myeloma | Major topic |
| Syndecan-1 | Major topic |
| Adult | |
| Aged | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Kaplan-Meier Estimate | |
| Male | |
| Middle Aged | |
| Protein Interaction Maps | |
| Sensitivity and Specificity |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28061985 | Multiple myeloma epidemiology and survival: A unique malignancy. | Semin Oncol | 2016 | https://conductscience.org/library/papers/28061985 | PubMed |
| 2 | 9834239 | Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-. | Blood | 1998 | https://conductscience.org/library/papers/9834239 | PubMed |
| 3 | 19131956 | Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. | Nat Protoc | 2009 | https://conductscience.org/library/papers/19131956 | PubMed |
| 4 | 21440298 | Stem cell marker nestin is expressed in plasma cells of multiple myeloma patients. | Leuk Res | 2011 | https://conductscience.org/library/papers/21440298 | PubMed |
| 5 | 22106282 | Role of checkpoint kinase 1 (Chk1) in the mechanisms of resistance to histone deacetylase inhibitors. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/22106282 | PubMed |
| 6 | 14630803 | Characterization of clonogenic multiple myeloma cells. | Blood | 2004 | https://conductscience.org/library/papers/14630803 | PubMed |
| 7 | 21034966 | The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. | Adv Cancer Res | 2010 | https://conductscience.org/library/papers/21034966 | PubMed |
| 8 | 19847258 | The DNA-damage response in human biology and disease. | Nature | 2009 | https://conductscience.org/library/papers/19847258 | PubMed |
| 9 | 23613359 | Roles of Chk1 in cell biology and cancer therapy. | Int J Cancer | 2014 | https://conductscience.org/library/papers/23613359 | PubMed |
| 10 | 31439945 | Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination. | Leukemia | 2020 | https://conductscience.org/library/papers/31439945 | PubMed |
| 11 | 2519615 | B lymphocytes express and lose syndecan at specific stages of differentiation. | Cell Regul | 1989 | https://conductscience.org/library/papers/2519615 | PubMed |
| 12 | 22766978 | Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide. | Int J Oncol | 2012 | https://conductscience.org/library/papers/22766978 | PubMed |
| 13 | 1675130 | 'Role of bone marrow stromal cells in the growth of human multiple myeloma. | Blood | 1991 | https://conductscience.org/library/papers/1675130 | PubMed |
| 14 | 18593978 | DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18593978 | PubMed |
| 15 | 25540889 | Multiple myeloma. | Lancet | 2015 | https://conductscience.org/library/papers/25540889 | PubMed |
| 16 | 21232653 | Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma. | Semin Hematol | 2011 | https://conductscience.org/library/papers/21232653 | PubMed |
| 17 | 25605792 | limma powers differential expression analyses for RNA-sequencing and microarray studies. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25605792 | PubMed |
| 18 | 9212098 | Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. | Nat Med | 1997 | https://conductscience.org/library/papers/9212098 | PubMed |
| 19 | 22430638 | CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients. | Leukemia | 2012 | https://conductscience.org/library/papers/22430638 | PubMed |
| 20 | 14597658 | Cytoscape: a software environment for integrated models of biomolecular interaction networks. | Genome Res | 2003 | https://conductscience.org/library/papers/14597658 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959892 | A proliferation score defined by PCLI-anchored transcriptomics predicts outcomes in multiple myeloma. | Blood Neoplasia | 2026 | https://conductscience.org/library/papers/42959892 | PubMed |
| 41596441 | Integrative Network Analysis of Single-Cell RNA Findings and a Priori Knowledge Highlights Gene Regulators in Multiple Myeloma Progression. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596441 | PubMed |
| 40786573 | Prognosis of multiple myeloma patients based on histopathological evaluation of bone marrow. | Caspian J Intern Med | 2025 | https://conductscience.org/library/papers/40786573 | PubMed |
| 40689313 | Diagnostic value of CD20 combined with CD138 positive expression in patients with chronic endometritis. | Am J Clin Exp Immunol | 2025 | https://conductscience.org/library/papers/40689313 | PubMed |
| 40594894 | Comprehensive machine learning analysis of PANoptosis signatures in multiple myeloma identifies prognostic and immunotherapy biomarkers. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594894 | PubMed |
| 38655136 | Targeted therapy for multiple myeloma: an overview on CD138-based strategies. | Front Oncol | 2024 | https://conductscience.org/library/papers/38655136 | PubMed |
| 36298586 | Seven Fatty Acid Metabolism-Related Genes as Potential Biomarkers for Predicting the Prognosis and Immunotherapy Responses in Patients with Esophageal Cancer. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36298586 | PubMed |
| 35252353 | A Neutrophil Extracellular Traps Signature Predicts the Clinical Outcomes and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/35252353 | PubMed |
| 34790661 | Prognostic Value of a Ferroptosis-Related Gene Signature in Patients With Head and Neck Squamous Cell Carcinoma. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34790661 | PubMed |
| 34257161 | Prognostic value of fatty acid metabolism-related genes in patients with hepatocellular carcinoma. | Aging (Albany NY) | 2021 | https://conductscience.org/library/papers/34257161 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33197893
GET https://conductscience.org/api/papers/v1/33197893/references?page=2